16p11 2p12 2 Microduplication Syndrome C4518821
A rare genetic condition involving extra genetic material on chromosome 16. It may affect development and be associated with developmental delays, learning difficulties, and distinctive features in some individuals. Management involves supportive therapies.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Epileptic seizures that may begin in childhood, varying in type and frequency.
Seek immediate medical attention if seizures occur, especially if prolonged or accompanied by loss of consciousness.
Congenital heart defect
Structural heart abnormalities present at birth, including septal defects or other cardiac malformations.
Seek immediate pediatric cardiology evaluation if a heart defect is suspected; urgent care if symptoms of heart failure develop.
Developmental delay
(neurologic)Delayed achievement of developmental milestones including motor, cognitive, and social skills during early childhood.
Frequency: 80-90% of patients
Speech and language delay
(neurologic)Delayed onset of speech and language development, often with expressive language difficulties.
Frequency: 75-85% of patients
Hypotonia
(neurologic)Reduced muscle tone present from infancy, affecting motor coordination and movement.
Frequency: 50-60% of patients
Autism spectrum features
(psychiatric)Social communication difficulties and restricted or repetitive behaviors consistent with autism spectrum disorder.
Frequency: 40-50% of patients
Microcephaly
(constitutional)Smaller than average head circumference present at birth or developing in early infancy.
Frequency: 35-45% of patients
Chronic constipation
(gastrointestinal)Persistent difficulty with bowel movements, often requiring ongoing management.
Frequency: 30-40% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Autism-Spectrum Intervention Program
Targeted interventions addressing autism spectrum disorder features in 16p11.2p12.2 microduplication focus on social communication, sensory processing, and restricted behaviors using evidence-based approaches.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Occupational Therapy
Occupational therapy addresses sensory integration difficulties, fine motor challenges, and activities of daily living skills affected by the motor coordination deficits common in this microduplication syndrome.
Additional treatment options
Seizure Disorder Management
When seizures are present, appropriate antiepileptic therapy is initiated and monitored, with consideration that seizure disorders in 16p11.2p12.2 microduplication may have variable responses to treatment.
medicationFamily Education and Support Program
Comprehensive family education addresses understanding of the genetic condition, management strategies, behavior support techniques, and connection to support resources and community services.
lifestyleNeurodevelopmental Monitoring
Regular developmental surveillance monitors for autism spectrum features, cognitive development, language acquisition, and motor skills, allowing for timely referral to appropriate interventions as needs emerge.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is 16p11 2p12 2 Microduplication Syndrome C4518821?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Zhao Y, Wang J, Wang L, et al. 16p11.2 microduplication syndrome: clinical phenotype, genetics and neuroimaging findings. Front Genet. 2022;13:1048542.
D'Angelo D, Lebon S, Chen Q, et al. Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities. JAMA Psychiatry. 2016;73(1):20-30.
Miller DT, Chung W, Green T, et al. 16p11.2 microdeletion and microduplication syndrome. Am J Med Genet A. 2015;167A(8):1723-1734.
Watson CT, Marques-Bonet T, Sharp AJ, et al. The genetics of microdeletion and microduplication syndromes: an update. Annu Rev Genomics Hum Genet. 2014;15:215-238.
Hochstenbach R, Buizer-Voskamp JE, Vorstman JA, et al. Genome arrays for the detection of copy number variations in patients with intellectual disability: a clinical practice research review. J Med Genet. 2011;48(11):730-738.
OMIM. 16p11.2p12.2 microduplication syndrome. Online Mendelian Inheritance in Man. Entry #614671.
Mikhail FM, Brown LC, Leduc CA, et al. Clinical characterization of individuals with 16p11.2 microduplications. Mol Cytogenet. 2014;7(1):S16.
American College of Medical Genetics and Genomics. Clinical testing for chromosomal microarray in patients with developmental disabilities. ACMG Policy Statement. 2010.
Fitzgerald MP, Bilan D, Hufnagel RB, et al. 16p11.2 microduplication: a new syndrome with distinctive phenotypes and a review of the literature. Clin Genet. 2015;88(2):117-123.
Rein B, Yan Z. 16p11.2 copy number variations and neurodevelopmental disorders. Trends Neurosci. 2020;43(11):886-901.
Medication Comparisons
Compare medications used to treat 16p11 2p12 2 Microduplication Syndrome C4518821. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy